Evaxion Biotech: Interview about the new ObsERV platform with CEO Per Norlén(video)
Research Interview
2023-03-24
13:06
Redeye interviews CEO Per Norlén about the new ObsERV platform which identifies endogenous retroviruses as targets for personalized cancer treatment.
RR
Richard Ramanius
Disclosures and disclaimers